Conmed (NYSE:CNMD) reported its Q2 earnings results on Wednesday, July 27, 2022 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Conmed beat estimated earnings by 1.33%, reporting an EPS of $0.76 versus an estimate of $0.75.
Revenue was up $22.03 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.08 which was followed by a 11.82% drop in the share price the next day.
Here’s a look at Conmed’s past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | 0.62 | 1.06 | 0.76 | 0.62 |
| EPS Actual | 0.70 | 1.07 | 0.80 | 0.71 |
| Revenue Estimate | 235.77M | 278.76M | 255.53M | 248.31M |
| Revenue Actual | 242.33M | 273.97M | 248.83M | 255.16M |
To track all earnings releases for Conmed visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
